These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of IUD related menorrhagia by indomethacin. Yarkoni S; Anteby SO Clin Exp Obstet Gynecol; 1984; 11(4):120-2. PubMed ID: 6437699 [TBL] [Abstract][Full Text] [Related]
6. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen). Roy S; Shaw ST Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136 [TBL] [Abstract][Full Text] [Related]
7. Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors. Anderson AB; Haynes PJ; Guillebaud J; Turnbull AC Lancet; 1976 Apr; 1(7963):774-6. PubMed ID: 56590 [TBL] [Abstract][Full Text] [Related]
8. The role of prostaglandin synthetase inhibitors in gynaecology. Anderson AB Practitioner; 1981 Oct; 225(1360):1460-70. PubMed ID: 6799953 [No Abstract] [Full Text] [Related]
9. The role of prostaglandins and allied substances in uterine haemostasis. Hagenfeldt K Contraception; 1987 Jul; 36(1):23-35. PubMed ID: 3311624 [TBL] [Abstract][Full Text] [Related]
10. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Milsom I; Andersson K; Andersch B; Rybo G Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665 [TBL] [Abstract][Full Text] [Related]
11. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908 [TBL] [Abstract][Full Text] [Related]
12. Menorrhagia, diffuse myometrial hypertrophy and the intrauterine contraceptive device: a report of fourteen cases. Honoré LH Acta Obstet Gynecol Scand; 1979; 58(3):283-5. PubMed ID: 484221 [TBL] [Abstract][Full Text] [Related]
13. Letter: Alleviation of IUD menorrhagia with ethamsylate. Harrison RF; Campbell S Br Med J; 1976 Mar; 1(6010):649-50. PubMed ID: 766907 [TBL] [Abstract][Full Text] [Related]
14. Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices. Ylikorkala O; Kauppila A; Siljander M Lancet; 1978 Aug; 2(8086):393-5. PubMed ID: 79760 [TBL] [Abstract][Full Text] [Related]
15. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. Ylikorkala O; Viinikka L Br J Obstet Gynaecol; 1983 Jan; 90(1):78-83. PubMed ID: 6336951 [TBL] [Abstract][Full Text] [Related]
16. Menorrhagia associated with the wearing of IUD--the results of treatment with clomiphene citrate. Bahari CM; Gorodesky IG; Neri A; Schachter A Eur J Obstet Gynecol Reprod Biol; 1982 Dec; 14(3):179-85. PubMed ID: 7160528 [TBL] [Abstract][Full Text] [Related]
17. [Study on clinical efficacy and mechanism of xiaoyan zhixue capsule in treating menorrhagia caused by intrauterine device]. Ren JF; Qu QH; Yu B; Liu Z Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jul; 24(7):605-9. PubMed ID: 15307698 [TBL] [Abstract][Full Text] [Related]
18. Uterine cavity and the location of IUDs following administration of meclofenamic acid to menorrhagic women. A pilot study. Pizarro E; Schöenstedt G; Mehech G; Hidalgo M; Romero C; Muñoz G Contraception; 1989 Oct; 40(4):413-23. PubMed ID: 2582768 [TBL] [Abstract][Full Text] [Related]
19. Hemorrhage induced by intrauterine devices: control by local proteinase inhibition. Tauber PF; Wolf AS; Herting W; Zaneveld LJ Fertil Steril; 1977 Dec; 28(12):1375-7. PubMed ID: 590549 [TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Tang GW; Lo SS Contraception; 1995 Apr; 51(4):231-5. PubMed ID: 7796588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]